These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 38466472

  • 1. Role of sirtuin 1 (SIRT1) in regulation of autophagy and nuclear factor-kappa Beta (NF-ĸβ) pathways in sorafenib-resistant hepatocellular carcinoma (HCC).
    Chan HY, Ramasamy TS, Chung FF, Teow SY.
    Cell Biochem Biophys; 2024 Jun; 82(2):959-968. PubMed ID: 38466472
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
    Liang Y, Zheng T, Song R, Wang J, Yin D, Wang L, Liu H, Tian L, Fang X, Meng X, Jiang H, Liu J, Liu L.
    Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
    [Abstract] [Full Text] [Related]

  • 3. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice.
    Lo J, Lau EY, Ching RH, Cheng BY, Ma MK, Ng IO, Lee TK.
    Hepatology; 2015 Aug; 62(2):534-45. PubMed ID: 25902734
    [Abstract] [Full Text] [Related]

  • 4. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Han P, Li H, Jiang X, Zhai B, Tan G, Zhao D, Qiao H, Liu B, Jiang H, Sun X.
    Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
    [Abstract] [Full Text] [Related]

  • 5. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 6. Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.
    Tai WT, Shiau CW, Chen HL, Liu CY, Lin CS, Cheng AL, Chen PJ, Chen KF.
    Cell Death Dis; 2013 Feb 07; 4(2):e485. PubMed ID: 23392173
    [Abstract] [Full Text] [Related]

  • 7. Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
    Kang D, Han Z, Oh GH, Joo Y, Choi HJ, Song JJ.
    Yonsei Med J; 2017 Sep 07; 58(5):899-909. PubMed ID: 28792132
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma.
    Liu D, Fan Y, Li J, Cheng B, Lin W, Li X, Du J, Ling C.
    Oncol Rep; 2018 Oct 07; 40(4):2206-2214. PubMed ID: 30066934
    [Abstract] [Full Text] [Related]

  • 9. CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells.
    Wang H, Qian Z, Zhao H, Zhang X, Che S, Zhang H, Shang H, Bao J, Hao C, Liu J, Li Z.
    Mol Med Rep; 2015 Sep 07; 12(3):3902-3908. PubMed ID: 26035694
    [Abstract] [Full Text] [Related]

  • 10. Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.
    Tovar V, Cornella H, Moeini A, Vidal S, Hoshida Y, Sia D, Peix J, Cabellos L, Alsinet C, Torrecilla S, Martinez-Quetglas I, Lozano JJ, Desbois-Mouthon C, Solé M, Domingo-Domenech J, Villanueva A, Llovet JM.
    Gut; 2017 Mar 07; 66(3):530-540. PubMed ID: 26658144
    [Abstract] [Full Text] [Related]

  • 11. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.
    Xiao Y, Sun L, Fu Y, Huang Y, Zhou R, Hu X, Zhou P, Quan J, Li N, Fan XG.
    BMC Cancer; 2017 Dec 15; 17(1):857. PubMed ID: 29246127
    [Abstract] [Full Text] [Related]

  • 12. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
    Chen JC, Chuang HY, Hsu FT, Chen YC, Chien YC, Hwang JJ.
    Oncotarget; 2016 Dec 20; 7(51):85450-85463. PubMed ID: 27863427
    [Abstract] [Full Text] [Related]

  • 13. Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Sun T, Liu H, Ming L.
    Cell Physiol Biochem; 2017 Dec 20; 44(2):716-727. PubMed ID: 29169150
    [Abstract] [Full Text] [Related]

  • 14. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY, Jung HU, Yoo SH, Yoo KS, Cheong J, Park BS, Yun I, Yoo YH.
    Cancer Lett; 2014 Dec 01; 355(1):61-9. PubMed ID: 25218348
    [Abstract] [Full Text] [Related]

  • 15. Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress.
    Zhai B, Hu F, Yan H, Zhao D, Jin X, Fang T, Pan S, Sun X, Xu L.
    PLoS One; 2015 Dec 01; 10(9):e0138485. PubMed ID: 26381511
    [Abstract] [Full Text] [Related]

  • 16. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Kabir TD, Ganda C, Brown RM, Beveridge DJ, Richardson KL, Chaturvedi V, Candy P, Epis M, Wintle L, Kalinowski F, Kopp C, Stuart LM, Yeoh GC, George J, Leedman PJ.
    Hepatology; 2018 Jan 01; 67(1):216-231. PubMed ID: 28833396
    [Abstract] [Full Text] [Related]

  • 17. Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.
    Fondevila F, Méndez-Blanco C, Fernández-Palanca P, Payo-Serafín T, van Pelt J, Verslype C, González-Gallego J, Mauriz JL.
    Int J Mol Sci; 2021 Oct 29; 22(21):. PubMed ID: 34769197
    [Abstract] [Full Text] [Related]

  • 18. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
    Hsu FT, Liu YC, Chiang IT, Liu RS, Wang HE, Lin WJ, Hwang JJ.
    Int J Oncol; 2014 Jul 29; 45(1):177-88. PubMed ID: 24807012
    [Abstract] [Full Text] [Related]

  • 19. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1.
    Dong ZB, Wu HM, He YC, Huang ZT, Weng YH, Li H, Liang C, Yu WM, Chen W.
    Cell Death Dis; 2022 Jan 10; 13(1):35. PubMed ID: 35013144
    [Abstract] [Full Text] [Related]

  • 20. Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1.
    Garten A, Grohmann T, Kluckova K, Lavery GG, Kiess W, Penke M.
    Int J Mol Sci; 2019 Aug 19; 20(16):. PubMed ID: 31430957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.